 |
Market Cap | 28.21M | EPS (ttm) | -10.81 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -4.60% |
P/S | 2.72 | EPS next 5Y | - |
P/B | 4.70 | EPS Q/Q | 9.02% |
Dividend | - | Sales Q/Q | -38.39% |
Insider Own | 45.24% | Inst Own | 10.05% |
Insider Trans | -2.15% | Inst Trans | 0.14% |
Short Float | 4.39% | Earnings | Mar 21/b |
Analyst Recom | 1.00 | Target Price | 900.00 |
Avg Volume | 29.87K | 52W Range | 2.71 - 84.44 |
|
|
|
Agrify Corp. engages in the development of hardware and software solutions for indoor agriculture. The company was founded on June 6, 2016 and is headquartered in Troy, MI. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Towns Brian | EVP - Extraction | Dec 03 '24 | Sale | 40.19 | 5,282 | 212,305 | 8,314 | Dec 05 09:01 PM | Holtzman Max | Director | Dec 03 '24 | Sale | 41.71 | 1,097 | 45,753 | 0 | Dec 05 09:01 PM | MAHONEY TIMOTHY | Director | Dec 03 '24 | Sale | 42.69 | 1,097 | 46,830 | 0 | Dec 05 09:01 PM | Kessler David Aaron | Chief Science Officer | Dec 03 '24 | Sale | 37.44 | 13,598 | 509,094 | 0 | Dec 05 09:00 PM | Brian Towns | Officer | Dec 06 '24 | Proposed Sale | 30.67 | 8,314 | 254,990 | | Dec 05 04:11 PM |
|
|
 |
 |
Market Cap | 26.55M | EPS (ttm) | -2.72 |
P/E | - | EPS this Y | -1.94% |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 21.16% |
P/S | 2.23 | EPS next 5Y | - |
P/B | - | EPS Q/Q | -1040.16% |
Dividend | - | Sales Q/Q | -9.82% |
Insider Own | 39.10% | Inst Own | 18.91% |
Insider Trans | -0.01% | Inst Trans | -13.54% |
Short Float | 2.88% | Earnings | Mar 21/b |
Analyst Recom | 2.00 | Target Price | 1.00 |
Avg Volume | 39.05K | 52W Range | 0.73 - 2.09 |
|
|
|
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. The firm also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. Its products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Patience David | Chief Financial Officer | Feb 26 '25 | Option Exercise | 0.00 | 1,500 | 0 | 51,919 | Feb 27 07:24 PM | Patience David | Chief Financial Officer | Feb 26 '25 | Sale | 1.09 | 535 | 583 | 51,384 | Feb 27 07:24 PM | Phillips Jack | Chief Executive Officer | Feb 01 '25 | Option Exercise | 0.00 | 1,000 | 0 | 163,919 | Feb 04 04:10 PM | Phillips Jack | Chief Executive Officer | Feb 03 '25 | Sale | 1.35 | 485 | 655 | 163,434 | Feb 04 04:10 PM | PATIENCE JOHN | Director | Dec 03 '24 | Buy | 1.57 | 200,000 | 314,000 | 653,224 | Dec 03 08:48 PM |
|
|
 |
 |
Market Cap | 7.63M | EPS (ttm) | -4.07 |
P/E | - | EPS this Y | 85.40% |
Forward P/E | 10.75 | EPS next Y | 117.02% |
PEG | - | EPS past 5Y | 29.20% |
P/S | 0.20 | EPS next 5Y | - |
P/B | 1.72 | EPS Q/Q | -109.55% |
Dividend | - | Sales Q/Q | 18.53% |
Insider Own | 17.39% | Inst Own | 21.11% |
Insider Trans | 0.00% | Inst Trans | -9.08% |
Short Float | 1.11% | Earnings | Mar 21/b |
Analyst Recom | 1.00 | Target Price | 14.00 |
Avg Volume | 405.41K | 52W Range | 0.65 - 2.43 |
|
|
|
Biofrontera, Inc. is a biopharmaceutical company, which engages in the commercialization of pharmaceutical products. It specializes in the treatment of dermatological conditions, caused primarily by exposure to sunlight that results in sun damage to the skin. The company is focused on the treatment of actinic keratosis and markets a topical antibiotic for treatment of impetigo. Its products include Ameluz and Xepi, its two prescription drugs, and BF-RhodoLED, a lamp used with Ameluz, for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company was founded on March 3, 2015 and is headquartered in Woburn, MA. |
|
|  |
 |
Market Cap | 27.10B | EPS (ttm) | 1.39 |
P/E | 15.04 | EPS this Y | 27.31% |
Forward P/E | 9.88 | EPS next Y | 17.24% |
PEG | 0.74 | EPS past 5Y | -19.76% |
P/S | 1.08 | EPS next 5Y | 20.22% |
P/B | 2.96 | EPS Q/Q | 707.63% |
Dividend | - | Sales Q/Q | 10.02% |
Insider Own | 17.88% | Inst Own | 57.40% |
Insider Trans | -0.01% | Inst Trans | -2.36% |
Short Float | 5.59% | Earnings | Mar 21/b |
Analyst Recom | 1.58 | Target Price | 29.87 |
Avg Volume | 22.59M | 52W Range | 13.78 - 28.72 |
|
|
|
Carnival Corp. engages in the operation of cruise ships. It operates through the following business segments: North America and Australia (NAA) Cruise, Europe and Asia (EA) Cruise Operations, Cruise Support, and Tour and Others. The North America and Australia (NAA) Cruise segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe and Asia (EA) Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Bernstein David | Officer | Feb 18 '25 | Proposed Sale | 25.88 | 80,000 | 2,070,400 | | Feb 14 04:14 PM | BAND SIR JONATHON | Director | Oct 29 '24 | Sale | 21.72 | 17,500 | 380,100 | 65,789 | Oct 31 11:50 AM | BAND SIR JONATHON | Director | Oct 29 '24 | Proposed Sale | 20.91 | 17,500 | 365,925 | | Oct 29 06:11 AM |
|
|
 |
 |
Market Cap | 790.90M | EPS (ttm) | -0.94 |
P/E | - | EPS this Y | 6.87% |
Forward P/E | - | EPS next Y | 25.60% |
PEG | - | EPS past 5Y | 8.31% |
P/S | 4943.12 | EPS next 5Y | - |
P/B | 5.63 | EPS Q/Q | 5.76% |
Dividend | - | Sales Q/Q | 136.36% |
Insider Own | 15.43% | Inst Own | 44.72% |
Insider Trans | -0.14% | Inst Trans | 25.42% |
Short Float | 6.01% | Earnings | Mar 21/b |
Analyst Recom | 2.60 | Target Price | 8.54 |
Avg Volume | 4.03M | 52W Range | 0.75 - 8.50 |
|
|
|
Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded in April 2000 and is headquartered in Durham, NC. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Melemed Allen S. | CHIEF MEDICAL OFFICER | Feb 13 '25 | Sale | 4.50 | 3,065 | 13,799 | 152,875 | Feb 14 05:50 PM | Andriole Michael T. | PRESIDENT AND CEO | Feb 13 '25 | Sale | 4.52 | 7,370 | 33,282 | 609,603 | Feb 14 05:49 PM | Alrutz Michael Albert | SVP AND GENERAL COUNSEL | Feb 13 '25 | Sale | 4.52 | 1,600 | 7,226 | 213,596 | Feb 14 05:48 PM | Jakeman David | VP OF FINANCE AND ACCOUNTING | Feb 13 '25 | Sale | 4.53 | 300 | 1,360 | 148,987 | Feb 14 05:47 PM | LaSpaluto Michelle | CHIEF FINANCIAL OFFICER | Feb 13 '25 | Sale | 4.51 | 2,260 | 10,196 | 172,977 | Feb 14 05:45 PM |
|
|
|  |
 |
Market Cap | 82.99M | EPS (ttm) | -1.78 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 26.59% |
P/S | 1.97 | EPS next 5Y | - |
P/B | - | EPS Q/Q | 83.91% |
Dividend | - | Sales Q/Q | 79.45% |
Insider Own | 16.57% | Inst Own | 3.31% |
Insider Trans | 0.00% | Inst Trans | 0.68% |
Short Float | 0.09% | Earnings | Mar 21/b |
Analyst Recom | 1.00 | Target Price | 55.88 |
Avg Volume | 18.50K | 52W Range | 6.10 - 25.70 |
|
|
|
51Talk Online Education Group engages in the operation of an online education platform in China. It operates under the China and Philippines geographical segments. Its online and mobile education platforms enable students across China to take live interactive english lessons with overseas foreign teachers on demand. The company was founded by Jia Jia Huang, Ting Shu, and Li Ming Zhang in July 2011 and is headquartered in Singapore. |
|
 |
 |
Market Cap | 2.71B | EPS (ttm) | 1.39 |
P/E | 13.41 | EPS this Y | 27.58% |
Forward P/E | 8.81 | EPS next Y | 17.04% |
PEG | 0.67 | EPS past 5Y | -19.76% |
P/S | 0.11 | EPS next 5Y | 19.94% |
P/B | 2.64 | EPS Q/Q | 707.63% |
Dividend | - | Sales Q/Q | 10.02% |
Insider Own | 0.01% | Inst Own | 29.84% |
Insider Trans | -54.62% | Inst Trans | -2.14% |
Short Float | 3.55% | Earnings | Mar 21/b |
Analyst Recom | 1.60 | Target Price | 29.81 |
Avg Volume | 1.81M | 52W Range | 12.50 - 26.14 |
|
|
|
Carnival Plc operates as a global cruise and vacation company. The firm offers holiday and vacation products to a customer base that is broadly varied in terms of cultures, languages and leisure-time preferences. It operates through the North America and Australia (NAA), Europe and Asia (EA), Cruise Support, and Tour and Other segments. The NAA segment includes Carnival Cruise Line, Holland America Line, P and O Cruises (Australia), Princess and Seabourn. The EA segment includes AIDA, Costa, Cunard, and P and O Cruises (UK). The Cruise Support segment includes a portfolio of port destinations and other services, all of which are operated for the benefit of cruise brands. The Tour and Other segment represents the hotel and transportation operations of Holland America Princess Alaska Tours and other operations. The company was founded on July 19, 2000 and is headquartered in Southampton, the United Kingdom. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Bernstein David | Officer | Feb 18 '25 | Proposed Sale | 25.88 | 80,000 | 2,070,400 | | Feb 14 03:59 PM | BAND SIR JONATHON | Director | Oct 29 '24 | Sale | 21.72 | 17,500 | 380,100 | 65,789 | Oct 31 11:52 AM | BAND SIR JONATHON | Director | Oct 29 '24 | Proposed Sale | 20.91 | 17,500 | 365,925 | | Oct 29 06:27 AM |
|
|
|  |
 |
Market Cap | 14.50M | EPS (ttm) | -11.69 |
P/E | - | EPS this Y | 49.24% |
Forward P/E | - | EPS next Y | 47.06% |
PEG | - | EPS past 5Y | 18.25% |
P/S | - | EPS next 5Y | 32.38% |
P/B | 0.44 | EPS Q/Q | -1.04% |
Dividend | - | Sales Q/Q | - |
Insider Own | 0.84% | Inst Own | 3.49% |
Insider Trans | 0.00% | Inst Trans | 2.67% |
Short Float | 8.20% | Earnings | Mar 21/b |
Analyst Recom | 1.67 | Target Price | 18.00 |
Avg Volume | 5.81M | 52W Range | 0.40 - 7.35 |
|
|
|
Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe on July 28, 2015 and is headquartered in Houston, TX. |
|
 |
 |
Market Cap | 5.84B | EPS (ttm) | 1.19 |
P/E | 15.87 | EPS this Y | 25.80% |
Forward P/E | 10.50 | EPS next Y | 23.70% |
PEG | 0.87 | EPS past 5Y | - |
P/S | 2.40 | EPS next 5Y | 18.34% |
P/B | 4.33 | EPS Q/Q | 6.11% |
Dividend | 3.76% | Sales Q/Q | 20.61% |
Insider Own | 0.85% | Inst Own | 10.35% |
Insider Trans | 0.00% | Inst Trans | 8.87% |
Short Float | 2.16% | Earnings | Mar 21/b |
Analyst Recom | 1.42 | Target Price | 26.57 |
Avg Volume | 1.07M | 52W Range | 12.51 - 27.71 |
|
|
|
MINISO Group Holding Ltd. engages in retail and wholesale of lifestyle and pop toy products. It operates through the MINISO Brand and TOP TOY Brand segments. The MINISO Brand segment involves in design, buying, and sale of lifestyle products. The TOP TOY Brand segment includes design, buying, and sale of pop toys. The company was founded by Guo Fu Ye in 2013 and is headquartered in Guangzhou, China. |
|
 |
 |
Market Cap | 138.12M | EPS (ttm) | -0.70 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -4.91% |
P/S | 32.35 | EPS next 5Y | - |
P/B | 7.67 | EPS Q/Q | 17.48% |
Dividend | - | Sales Q/Q | -16.45% |
Insider Own | 22.63% | Inst Own | 14.82% |
Insider Trans | 0.00% | Inst Trans | 5.80% |
Short Float | 4.59% | Earnings | Mar 21/b |
Analyst Recom | 1.00 | Target Price | 16.50 |
Avg Volume | 93.04K | 52W Range | 1.24 - 15.00 |
|
|
|
Neonode, Inc. engages in the provision of advanced optical sensing solutions for contactless touch, touch, and gesture sensing. It offers software solutions for scene analysis that feature advanced machine learning algorithms to detect and track persons and objects in video streams for cameras and other types of imagers. It operates through the following geographical segments: United States, Japan, South Korea, China, Germany, Switzerland, and Other. The company was founded by Thomas Eriksson Bjorn on September 4, 1997 and is headquartered in Stockholm, Sweden. |
|
|